Thermo King launches cold storage solutions to support COVID-19 vaccine distribution

Thermo King by Trane Technologies, has expanded its portfolio of temporary storage solutions that can meet the unique requirements of global pharmaceutical companies developing COVID-19 vaccines. Thermo King is the global leader in intelligent end-to-end temperature-controlled cold chain solutions.

Pharmaceutical companies in final-stage clinical trials anticipate they will require strict temperature controls to safeguard their products – down to temperatures as low as (-) 70 degrees Celsius. Thermo King’s solutions can enable these companies and their distributors to ensure the efficacy of their products through the entire cold chain – from air transport to marine, rail, trailer, last-mile delivery and at storage points along the way.

According to the World Health Organization, nearly 20 percent of temperature-sensitive health care products are damaged during transport, and 25 percent of vaccines reach their destination in a degraded state due to breaks in the cold chain.

“Considering the urgent, global need for a COVID-19 vaccine, the world can’t afford breaks in the cold chain,” said Dave Regnery, president and chief operating officer of Trane Technologies. “Our new Cold Storage Solutions can maintain temperatures of (-) 70 degrees Celsius for an extended period of time, can be leveraged to help reduce degradation of a vaccination, and most importantly, could prevent vaccine ‘deserts’ or lack of accessibility.”